Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Sacred Heart University (USC) | - |
Autor(es): dc.creator | Momesso, Gustavo Antonio Correa [UNESP] | - |
Autor(es): dc.creator | Lemos, Cleidiel Aparecido Araújo [UNESP] | - |
Autor(es): dc.creator | Santiago-Júnior, Joel Ferreira | - |
Autor(es): dc.creator | Faverani, Leonardo Perez [UNESP] | - |
Autor(es): dc.creator | Pellizzer, Eduardo Piza [UNESP] | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:33:53Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:33:53Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-06-01 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1007/s10006-020-00831-0 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/201569 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/201569 | - |
Descrição: dc.description | Purpose: The aim of this study was to perform a systematic review and meta-analysis to evaluate the efficacy of laser therapy on medication-related osteonecrosis of the jaw (MRONJ) treatment. Methods: This study followed PRISMA standards, and an electronic search was performed on the PubMed/MEDLINE, Scopus, and Cochrane databases. Eighty-nine articles were found. After reading the manuscripts, 15 articles remained for the review. Three of them were selected for meta-analysis. Results: Female gender was predominant (72.5%), and mean age was 66.5 years. Follow-up varied between 3 and 80 months, and the most used bisphosphonate was zoledronic acid (71.6%). Stage II of MRONJ was the most prevalent (68.9%), and the mandible was the most affected site (64.5%). Qualitative data showed that treatment with laser surgery (Er:YAG) was most effective regarding complete healing of the lesion (90%) compared with other treatments. Meta-analysis data showed that low-level laser therapy (LLLT) was more effective than medical treatment (P = 0.006), and surgical treatment was more effective than LLLT (P = 0.008). Conclusion: Laser surgery was significantly superior to LLLT (p < 0.00001). Therefore, laser surgical therapy seems to be a great management strategy for MRONJ treatment from stage II. LLLT was shown to improve conservative management in earlier MRONJ stages. | - |
Descrição: dc.description | Department of Diagnosis and Surgery Aracatuba Dental School São Paulo State University (UNESP) | - |
Descrição: dc.description | Department of Dental Materials and Prosthodontics School of Dentistry São Paulo State University (UNESP) | - |
Descrição: dc.description | Department of Health Sciences Sacred Heart University (USC) | - |
Descrição: dc.description | Department of Diagnosis and Surgery Aracatuba Dental School São Paulo State University (UNESP) | - |
Descrição: dc.description | Department of Dental Materials and Prosthodontics School of Dentistry São Paulo State University (UNESP) | - |
Formato: dc.format | 133-144 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Oral and Maxillofacial Surgery | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Bisphosphonate | - |
Palavras-chave: dc.subject | Laser therapy | - |
Palavras-chave: dc.subject | Low-level laser therapy | - |
Palavras-chave: dc.subject | Medication-associated osteonecrosis of the jaw | - |
Título: dc.title | Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: